Skip to content

Clinical Trial between Bhadrotkatadya Avaleha and Panchakola Churna in sutika shool.

A randomized open labelled comparative clinical study to evaluate the efficacy of bhadrotkatadya avaleha and panchakola churna in the management of sutika sula - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101279
Enrollment
40
Registered
2026-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O909- Complication of the puerperium, unspecified

Interventions

None listed

Sponsors

Shree Swaminarayan Ayurvedic College, Kalol
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Women aged 18 40 years who have delivered within 7 days (vaginal delivery primi & multi) 2.Presenting with symptoms as per diagnostic criteria 3.Willing to participate and comply with follow-up for 60 days 4.Capable of providing written informed consent

Exclusion criteria

Exclusion criteria: 1.Age below 18 years or above 40 years 2.Cesarean delivery, instrumental delivery, or manual removal of placenta 3.Spinal conditions Pott s spine (TB spine),Spinal cord compression,History of trauma or surgery to spine/lower back 4.Rheumatoid arthritis, ankylosing spondylitis, or other systemic musculoskeletal disorders 5.Severe anemia (Hb less than 8gm percent) or postpartum hemorrhage (PPH) 6.Back pain due to structural disc prolapse, vertebral fracture, or known neurological condition 7.Patients with uncontrolled diabetes

Design outcomes

Primary

MeasureTime frame
Significant reduction in Sutika sula as assessed by. Visual Analogue Scale (VAS) Timepoint: Baseline day 30

Secondary

MeasureTime frame
Improvement in associated symptoms such as Adhmana Agnimandya Regularization of mala and mutra vegas improved subjective feeling of comfort, and well being during postpartum recovery High Tolerability and compliance to Bhadrotkatadya Avaleha without significant adverse effect during and after treatmentTimepoint: Baseline day 30

Countries

India

Contacts

Public ContactDr Vaibhavi Shripati

Shree Swaminarayan Ayurvedic College and Hospital Kalol

ranjanaingale7396@gmail.com9909945110

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026